pamidronate has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naqvi, A | 1 |
| Cuchacovich, R | 1 |
| Saketkoo, L | 1 |
| Espinoza, LR | 1 |
| Jude, EB | 1 |
| Selby, PL | 1 |
| Burgess, J | 1 |
| Lilleystone, P | 1 |
| Mawer, EB | 1 |
| Page, SR | 1 |
| Donohoe, M | 1 |
| Foster, AV | 1 |
| Edmonds, ME | 1 |
| Boulton, AJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.[NCT04547348] | Phase 3 | 38 participants (Anticipated) | Interventional | 2020-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for pamidronate and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
Topics: Adult; Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Arthropathy, Neurogenic; Biomarkers; Bo | 2001 |
1 other study available for pamidronate and Asymmetric Diabetic Proximal Motor Neuropathy
| Article | Year |
|---|---|
Acute Charcot arthropathy successfully treated with pamidronate: long-term follow-up.
Topics: Aged, 80 and over; Arthropathy, Neurogenic; Bone Density Conservation Agents; Diabetes Mellitus, Typ | 2008 |